::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

:: PHARMESIS INTERNATIONAL LTD.

Established in 1995 to 1996, Pharmesis specialises in the research and development, production, sale and marketing of Western medicine and TCM (Traditional Chinese Medicine) formulated products for the treatment of illnesses relating to the liver and gall bladder.

Our two leading pharmaceutical products are ATT (anetholtrithione) tablets, a Western medicine marketed under the “国嘉” brand, and TCM formulated Gansu granules marketed under the “古蔺肝苏” brand. These products are sold to approximately 2,000 hospitals all over the PRC through an established sales and marketing network.
 
   :: OUR BRANDS
KINNA (for western medicine)
 
LONGLIFE (for TCM fomulated products)
Copyright © 2000-2014 Pharmesis | Terms & Conditions